Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)
Recruiting now · Phase 4 · Has a placebo group
Conditions studied: Stress Urinary Incontinence
In brief
The primary aim of this study is to assess the utility of prophylactic oral antibiotics at time of Bulkamid transurethral bulking to reduce the incidence of urinary tract infection (UTI) in the immediate postoperative period. The secondary aims of the study include assessing UTI rates and success rates if patients require temporary indwelling catheter versus intermittent self-catheterization (ISC).
Key facts
- Study ID
- NCT06706362
- Run by
- Ohio State University
- People needed
- 138
- Starts
- 2025-09-15
- Expected to finish
- 2027-10-15
- Last updated by the study team
- 2025-10-08
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients evaluated by a pelvic floor specialist (either urogynecologist or urologist) at The Ohio State University with plans to undergo urethral bulking with Bulkamid for stress urinary incontinence or mixed urinary incontinence (stress predominant).
- Negative testing for UTI in pre-operative work-up (including either negative urine culture or urine dip negative for infection).
- Office evaluation with evidence of SUI either with urodynamic studies (UDS) or positive cough stress test (CST).
- Post-void residual volume of 150 mL or less (measured by either catheterization or bladder scan)
You may not qualify if…
- Contraindications to both oral antibiotics including antibiotic allergies or significant renal disease
- Patient undergoing additional pelvic organ prolapse procedures or other urologic procedures concomitantly
- Recurrent UTIs, defined as 3 or more UTIs within the past 12 months or 2 UTIs within the past 6 months
- Patients currently taking daily antibiotic prophylaxis for any reason
- Non-English speaking patients
- Pregnant patients
- Pelvic organ prolapse stage greater than 2
- Patients with immunosuppression due to underlying medical conditions
- Recent antibiotic treatment within one week of the procedure
Where it is running
- The Ohio State University Wexner Medical Center OB/GYN Female Pelvic Medicine and Reconstructive Surgery — Columbus, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.